BR112018069193A2 - uma vacina de combinação contra infecção por vírus pcv2 e prrs compreendendo albumina - Google Patents
uma vacina de combinação contra infecção por vírus pcv2 e prrs compreendendo albuminaInfo
- Publication number
- BR112018069193A2 BR112018069193A2 BR112018069193A BR112018069193A BR112018069193A2 BR 112018069193 A2 BR112018069193 A2 BR 112018069193A2 BR 112018069193 A BR112018069193 A BR 112018069193A BR 112018069193 A BR112018069193 A BR 112018069193A BR 112018069193 A2 BR112018069193 A2 BR 112018069193A2
- Authority
- BR
- Brazil
- Prior art keywords
- prrs virus
- albumin
- virus infection
- vaccine against
- combination vaccine
- Prior art date
Links
- 102000009027 Albumins Human genes 0.000 title abstract 2
- 108010088751 Albumins Proteins 0.000 title abstract 2
- 230000009385 viral infection Effects 0.000 title abstract 2
- 229940001442 combination vaccine Drugs 0.000 title 1
- 229960005486 vaccine Drugs 0.000 abstract 3
- 241000202347 Porcine circovirus Species 0.000 abstract 1
- 241001673669 Porcine circovirus 2 Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000003362 replicative effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16161982 | 2016-03-23 | ||
| PCT/EP2017/056801 WO2017162727A1 (en) | 2016-03-23 | 2017-03-22 | A combination vaccine against pcv2 and prrs virus infection comprising albumin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018069193A2 true BR112018069193A2 (pt) | 2019-01-29 |
Family
ID=55589749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018069193A BR112018069193A2 (pt) | 2016-03-23 | 2017-03-22 | uma vacina de combinação contra infecção por vírus pcv2 e prrs compreendendo albumina |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10953084B2 (https=) |
| EP (1) | EP3432921A1 (https=) |
| JP (1) | JP2019509302A (https=) |
| CN (1) | CN108778325A (https=) |
| BR (1) | BR112018069193A2 (https=) |
| RU (1) | RU2018137036A (https=) |
| WO (1) | WO2017162727A1 (https=) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2007130801A (ru) | 2005-01-13 | 2009-02-20 | Берингер Ингельхайм Ветмедика Гмбх (De) | Улучшенные вакцины против репродуктивно-респираторного синдрома свиней (prrs) |
| ES2425228T3 (es) | 2005-09-09 | 2013-10-14 | Intervet International B.V. | Vacuna contra el PCV-2 |
| DK3766518T3 (da) | 2005-12-29 | 2026-04-13 | Boehringer Ingelheim Animal Health Usa Inc | Immunogen pcv2-sammensætning til mindskelse af kliniske symptomer hos grise |
| PT2094872T (pt) | 2006-12-15 | 2017-04-27 | Boehringer Ingelheim Vetmedica Inc | Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2 |
| US8728487B2 (en) | 2011-01-20 | 2014-05-20 | Hua Wu | Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome |
| US9120859B2 (en) * | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
| US9457073B2 (en) | 2012-09-26 | 2016-10-04 | University Of Manitoba | Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity |
| EP2991676A1 (en) | 2013-04-30 | 2016-03-09 | Boehringer Ingelheim Vetmedica, Inc. | Orf2 protein of pcv2 subtype a (pcv2a) for use in cross-protection |
| TWI670085B (zh) * | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
| CN104056265B (zh) * | 2014-07-11 | 2016-04-27 | 江苏南农高科技股份有限公司 | 猪圆环病毒2型、猪繁殖与呼吸综合征二联疫苗及其制备方法 |
-
2017
- 2017-03-22 US US16/086,629 patent/US10953084B2/en active Active
- 2017-03-22 JP JP2018549454A patent/JP2019509302A/ja not_active Withdrawn
- 2017-03-22 CN CN201780017516.9A patent/CN108778325A/zh active Pending
- 2017-03-22 EP EP17711679.5A patent/EP3432921A1/en active Pending
- 2017-03-22 WO PCT/EP2017/056801 patent/WO2017162727A1/en not_active Ceased
- 2017-03-22 BR BR112018069193A patent/BR112018069193A2/pt not_active IP Right Cessation
- 2017-03-22 RU RU2018137036A patent/RU2018137036A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN108778325A (zh) | 2018-11-09 |
| WO2017162727A1 (en) | 2017-09-28 |
| EP3432921A1 (en) | 2019-01-30 |
| US10953084B2 (en) | 2021-03-23 |
| RU2018137036A3 (https=) | 2020-06-04 |
| US20190091321A1 (en) | 2019-03-28 |
| JP2019509302A (ja) | 2019-04-04 |
| RU2018137036A (ru) | 2020-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2021006308A2 (es) | Proteínas f de prefusión del vrs estabilizadas | |
| MX2018014573A (es) | Vacuna contra el virus del zika. | |
| CL2019003805A1 (es) | Composiciones inmunógenas de senecavirus a y métodos de éstas. | |
| MX2019007349A (es) | Vacuna combinada para cerdos. | |
| BR112018069100A2 (pt) | uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae | |
| CO6551750A2 (es) | Vacuna del virus del dengue inactivado que incluye un adyuvante sin aluminio | |
| CL2017001961A1 (es) | Vacuna bivalente contra el virus de gripe porcina | |
| CL2016002276A1 (es) | Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad | |
| BR112019006802A2 (pt) | compostos e métodos para diagnóstico e tratamento de infecções virais | |
| AR108829A1 (es) | Vacuna contra virus de bronquitis infecciosa | |
| BR112018075440A2 (pt) | composições e métodos para prevenir e tratar a infecção por zika vírus | |
| UY32208A (es) | Uso de antigeno de mycoplasma bovis | |
| MX2018006416A (es) | Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina. | |
| BR112021019859A2 (pt) | Vacinas de circovírus suíno tipo 3 (pcv3) e produção e seus usos | |
| PH12018501368A1 (en) | M hyo multivalent vaccine and uses thereof | |
| BR112015031226A2 (pt) | Composição de vacina, e, uso da composição de vacina | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
| CL2017001595A1 (es) | Composiciones de vacuna para el virus del dengue y métodos de uso de las mismas | |
| BR112018014723A2 (pt) | fantasmas bacterianos para o tratamento de câncer | |
| BR112016012393A2 (pt) | Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado | |
| BR112022019207A2 (pt) | Composições de vacina para coronavírus e métodos de uso das mesmas | |
| BR112014023092A8 (pt) | Composição imunogênica, método para a prevenção de infecção ou doença por hpv em um indivíduo, e, kit | |
| BR112018069193A2 (pt) | uma vacina de combinação contra infecção por vírus pcv2 e prrs compreendendo albumina | |
| BR112018069219A2 (pt) | uma vacina para aplicação intradérmica contra infecção pelo vírus pcv2 e prrs | |
| MX2019012220A (es) | Vacunas que contienen patogenos de cerdo para uso no mixto asociado. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2663 DE 18-01-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |